Overview

Random-start Ovarian Stimulation in Egg-donors (ROSE)

Status:
Terminated
Trial end date:
2018-01-12
Target enrollment:
Participant gender:
Summary
The purpose of this prospective single-center study is to evaluate the laboratory outcome after random start ovarian stimulation in oocyte donors. The study will be performed in egg-donors but this type of treatment has the potential to be implemented in general infertility population.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto Bernabeu
Treatments:
Cetrorelix
Deslorelin
Prolactin Release-Inhibiting Factors
Triptorelin Pamoate